| Report ID | 278522 |
| Drug Identification Number | 01935941 |
| Brand name | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML |
| Common or Proper name | Heparin Sodium in Dextrose |
| Company Name | B. BRAUN MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPARIN SODIUM SODIUM PHOSPHATE DIBASIC CITRIC ACID DEXTROSE |
| Strength(s) | 5000UNIT 410MG 93MG 5G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-02-27 |
| Actual start date | |
| Estimated end date | 2026-04-01 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
| Company contact information | Cindy Katsempris; [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-20 | French | Compare |
| v1 | 2026-02-20 | English | Compare |
Showing 1 to 2 of 2